Article

SLC39A1 contribute to malignant progression and have clinical prognostic impact in gliomas

2020-09-23

Abstract excerpt

<title>Abstract</title> <p>BackgroundGliomas are one of the most common primary tumors of the central nervous system, and have an unfavorable prognosis. SLC39A1 is a zinc ion transport protein which inhibits the progression of prostate cancer. By studying the role and mechanism of SLC39A1 in the progression of gliomas, perhaps a new therapeutic target can be provided for their treatment.MethodThe TCGA, CCGA, GSE1...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 0e1fc464-a2d3-5d55-aabd-db33169aec59
DOI: 10.21203/rs.3.rs-78711/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

SLC39A1 contribute to malignant progression and have clinical prognostic impact in gliomasDOI 10.21203/rs.3.rs-78711/v1Read

SLC39A1 Contribute to Malignant Progression and Have Clinical Prognostic Impact in GliomasSemantic proximity Read

SLC12A9 is an immunological and prognostic biomarker for glioma.Semantic proximity Read

Correlation of Prognostic Biomarker SLC25A1 with Immune Infiltrates in Low-Grade GliomasSemantic proximity Read

Cuproptosis-related Gene Slc31a1 Expression Correlates With the Prognosis and Tumor Immune Microenvironment in GliomaSemantic proximity Read

Cuproptosis-related gene SLC31A1 expression correlates with the prognosis and tumor immune microenvironment in gliomaSemantic proximity Read

Identification of SLC1A5 as a Novel Candidate Oncogene for Glioma and Its Involvement in the LGG Immune MicroenvironmentSemantic proximity Read

SLC43A3 Promotes Oncogenesis and Predicts Poor Prognosis in GliomaSemantic proximity Read

Pan-Cancer Analysis of the Solute Carrier Family 39 Genes in Relation to Oncogenic, Immune Infiltrating, and Therapeutic TargetsSemantic proximity Read

PSMC2/E2F1 Axis Promotes the Development and Progression of GliomaSemantic proximity Read

SLC1A5 enhances malignant phenotypes through modulating ferroptosis status and immune microenvironment in gliomaSemantic proximity Read

SLC1A5 Enhances Malignant Phenotypes Through Modulating Ferroptosis Status and Immune Microenvironment in GliomaSemantic proximity Read

Identification of tumor-associated antigens and immune subtypes of lower-grade glioma and glioblastoma for mRNA vaccine developmentSemantic proximity Read